The global platysmaplasty treatment market size was estimated at USD 1.07 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030. The market is experiencing robust growth due to a strong demand for cosmetic procedures that aim to improve the appearance of the neck and jawline. Platysmaplasty, a surgical procedure primarily focused on correcting and enhancing the neck and jawline, involves tightening the platysma muscles responsible for neck and jowl sagging, resulting in a more youthful and well-defined neck contour. The growth can be attributed to various factors such as the increasing emphasis on physical appearance and youthfulness, rising disposable income among individuals, and advancements in surgical techniques.
These factors contribute to a positive outlook for market growth, driven by a growing awareness of aesthetic procedures and the desire to maintain a youthful appearance. This trend is particularly evident in the rising interest in platsymaplasty surgeries, which specifically target neck and jawline enhancement. According to the American Society of Plastic Surgeons’ report, around 160,235 neck lifts were performed in the United States in 2020, which further supports this trend. As people have become more conscious of their overall appearance and strive to achieve a youthful and attractive look, the demand for platsymaplasty procedures continues to grow, highlighting the importance of these surgeries in meeting the aesthetic preferences and needs of individuals seeking facial enhancement.
The platysmaplasty treatment industry is primed for expansion, driven by advancements in innovative technologies and techniques within cosmetic surgery. Notably, the introduction of the Xact device by Cypris Medical in 2019 has provided a minimally invasive solution for face and neck lift suturing, improving outcomes, and enhancing safety in platsymaplasty procedures. This development appeals to individuals seeking neck contour enhancements. Moreover, the market benefits from a growing number of skilled plastic surgeons specializing in platsymaplasty, delivering a high standard of care and contributing to market growth by ensuring patient satisfaction and safety.
The market has been profoundly impacted by the COVID-19 pandemic, resulting in significant disruptions to its growth and operations. With healthcare systems prioritizing COVID-19 management, elective surgeries such as platsymaplasty were postponed or canceled, leading to a notable decline in procedures and demand. According to the International Society of Aesthetic Plastic Surgery, there was approximately 10.9% decrease in plastic surgery procedures worldwide; in addition, a substantial 77.8% of surgeons globally faced temporary practice closures due to the pandemic, further contributing to the decline in surgical activities within the field. Moreover, the implementation of lockdown measures, travel restrictions, and financial uncertainties prompted individuals to redirect their focus and resources away from aesthetic procedures, including platsymaplasty, as health and safety became paramount. However, as vaccination efforts progressed and the situation stabilized, the market recovered. As people regain confidence and the fear of the virus diminishes, the pursuit of aesthetic enhancements, including neck and jawline procedures, is likely to resume, propelling the market back onto its growth trajectory.
Based on gender, the market is classified into male and female segments. The female segment dominated the market with a 61.1% share in 2022 and is anticipated to witness the highest CAGR of 7.2% during the forecast period. The dominance of the female segment in the market can be attributed to various factors, including societal pressure and the desire to maintain a youthful neck and jawline. Women particularly have shown a strong demand for platysmaplasty procedures, driven by their increasing awareness of aesthetic options and their willingness to invest in enhancing their appearance. According to the plastic surgery statistics report of 2020, out of the total 160,235 neck lift procedures performed, approximately 138,051 were carried out on females, with a significant number of 97,588 procedures performed in the age range of 55-69.
The male segment is showing significant growth; this growth is driven by the growing acceptance and normalization of cosmetic procedures among men. As societal attitudes evolve and men become more open to pursuing aesthetic enhancements, there has been a significant increase in the demand for platysmaplasty procedures.
In terms of end-use, the market is classified into cosmetic surgery clinics and hospitals segments. The cosmetic surgery clinics segment dominated the market in 2022 with a share of 62.0% and it is anticipated to witness the highest CAGR of 7.9% during the forecast period. This segment’s ascendancy can be attributed to several factors, including the increasing demand for non-invasive and minimally invasive cosmetic procedures, and advancements in technology and techniques. With the rising focus on enhancing physical appearance, cosmetic surgery clinics are poised to continue dominating the market, catering to the ever-growing consumer base seeking safe and effective solutions for neck rejuvenation and cosmetic enhancement.
The hospitals segment is experiencing significant growth in the market due to hospitals being equipped with advanced infrastructure and state-of-the-art surgical facilities, which instill confidence in patients seeking platysmaplasty procedures. In addition, hospitals often employ highly skilled and specialized medical professionals who have extensive experience in performing complex surgeries such as platysmaplasty.
In terms of region, North America dominated the market in 2022 with a revenue share of 35.4%. The dominance in the market can be attributed to several key factors. The region boasts a highly developed healthcare infrastructure that offers advanced surgical techniques and cutting-edge technologies, making it an attractive destination for individuals seeking cosmetic procedures like platysmaplasty. Moreover, North America's significant patient population actively seeking aesthetic enhancements further drives the demand for such treatments. The presence of skilled and experienced surgeons specializing in facial rejuvenation procedures adds to the region's competitive advantage. An example of North America's market dominance is evident in the statistics provided by The American Society of Plastic Surgeons, which reported that the U.S. had the largest number of cosmetic treatments globally, encompassing a variety of surgical and minimally invasive procedures, including reconstructive surgeries.
However, Asia Pacific is expected to witness the fastest CAGR of 9.2% over the forecast period. The growth is due to the rising disposable income and improving standards of living that have led to an increased demand for cosmetic procedures, including those related to facial aesthetics like platysmaplasty. In addition, the growing awareness and acceptance of aesthetic treatments in Asia Pacific have contributed to the surge in demand.
Market players are introducing advanced services at affordable prices to increase their share. Key players are implementing strategic initiatives, such as expansion, offering advanced services, and marketing, to maximize their market dominance. Some prominent players in the global platysmaplasty treatment market include:
Long Island Plastic Surgical Group
Dr. Cat Plastic Surgery
Nazarian Plastic Surgery
Avenue Plastic Surgery
Piedmont Plastic Surgery & Dermatology
The Istanbul Aesthetic Center
The Esthetic Clinics
Los Angeles Plastic Surgery Clinic
Report Attribute |
Details |
Market size value in 2023 |
USD 1.14 billion |
Revenue forecast in 2030 |
USD 1.89 billion |
Growth rate |
CAGR of 7.5% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Gender, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Long Island Plastic Surgical Group; Dr. Cat Plastic Surgery; Nazarian Plastic Surgery; Avenue Plastic Surgery; Piedmont Plastic Surgery & Dermatology; The Istanbul Aesthetic Center; The Esthetic Clinics; Los Angeles Plastic Surgery Clinic |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to Country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global platysmaplasty treatment marketreport based on gender, end-use, and region:
Gender Outlook (Revenue, USD Million, 2018 - 2030)
Male
Female
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Cosmetic Surgery Clinics
Hospitals
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
b. The global platysmaplasty treatment market size was estimated at USD 1.07 billion in 2022 and is expected to reach USD 1.14 billion in 2023.
b. The global platysmaplasty treatment market is expected to grow at a compound annual growth rate of 7.5% from 2023 to 2030to reach USD 1.89 billion by 2030.
b. North America dominated the platysmaplasty treatment market and accounted for 35.4% of the total market share in 2022. The dominance in the Platysmaplasty Treatment Market can be attributed to several key factors. The region boasts a highly developed healthcare infrastructure that offers advanced surgical techniques and cutting-edge technologies, making it an attractive destination for individuals seeking cosmetic procedures like platysmaplasty
b. Some key players operating in the platysmaplasty treatment market include Long Island Plastic Surgical Group, Dr. Cat Plastic Surgery, Nazarian Plastic Surgery, Avenue Plastic Surgery, Piedmont Plastic Surgery & Dermatology, The Istanbul Aesthetic Center, The Esthetic Clinics, Los Angeles Plastic Surgery Clinic
b. The Platysmaplasty Treatment Market is experiencing robust growth due to a strong demand for cosmetic procedures that aim to improve the appearance of the neck and jawline. The growth can be attributed to various factors such as the increasing emphasis on physical appearance and youthfulness, rising disposable income among individuals, and advancements in surgical techniques
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."